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Abstract
Background: Use of acupuncture has widely increased in patients with chronic low back pain. However, the evidence 
supporting its efficacy remains unclear. In this article, we report the design and the protocol of a multi-center 
randomized sham-controlled trial to treat chronic low back pain. Our goal is to verify the effect of acupuncture on 
chronic low back pain.
Methods/Design: This study is a multi-center randomized sham-controlled trial with 2 parallel arms. Participants 
included in the study met the following criteria: 1) low back pain lasting for at least the last 3 months, 2) a documented 
≥ 5 points on a 10 cm visual analog scale for bothersomeness of low back pain at the time of screening and 3) between 
18 and 65 years of age. Participants were blinded to the real and sham acupuncture treatments. The real acupuncture 
treatment group received real acupuncture 2 times a week, during a total of 12 sessions over 6 weeks. The control 
group received sham acupuncture during the same period. In order to assess the primary and secondary outcome 
measures, the participants were asked to fill out a questionnaire at the baseline and 6, 8, 12 and 24 weeks after starting 
the treatments. The primary outcome was measured using the visual analog scale for bothersomeness of low back 
pain at 8 weeks after the initiation of treatments.
Discussion: The result of this trial (which will be available in 2010) will demonstrate the efficacy of using acupuncture 
to treat chronic low back pain.
Trial registration: This study is registered with the U.S. National Institutes of Health Clinical Trials registry: 
NCT00815529
Background
Chronic low back pain (LBP) is one of the most important
public health problems, as well as one of the main causes
of disability among adults of working age [1]. More than
50% of adults are bothered by back pain each year and
over 70% of adults have suffered from back pain at some
time in their lives [2,3].
Although a wide range of standard treatments are avail-
able [4], back pain patients are often dissatisfied with
conventional medical care [5]. Acupuncture is one of the
frequently used methods in patients with low back pain
[6]. Especially in Korea, where acupuncture has a much
longer tradition than in other countries, low back pain is
the first reason that people consult with the Korean Med-
icine Doctor (KMD) for acupuncture treatment [7]. A
number of randomized controlled trials (RCTs) on acu-
puncture for LBP have already been published [8,9].
However, conclusions regarding the efficacy and effec-
tiveness of acupuncture for this common problem
remains contradictory [8,9]. Most of these equivocal
results are due to low methodological quality, small sam-
ple size, and other factors such as inherent difficulties in
the use of controls [8-10]. Acupuncture is complicated to
evaluate because it is difficult to isolate the characteristic
or specific effects of the technique from the non-specific
ones [11]. Some reviews have noted the poor quality of
research in this area and have insisted on scientifically
rigorous studies [8-10].
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In this paper, we propose a randomized, sham-con-
trolled study of patients with chronic low back pain, with
a predetermined sample size and appropriate follow-up,
which will enable us to investigate the efficacy of acu-
puncture on chronic low back pain.
Methods & Design
Overview
This study is a multicenter, randomized, non-penetrating
sham-controlled study. The trial was conducted in the
following three hospitals after obtaining permission from
the Institutional Review Boards of three institutions:
East-West Neo Medical Center of Kyung Hee University,
O r i e n t a l  M e d i c i n e  H o s p i t a l  o f  S a n g  J i  U n i v e r s i t y ,  a n d
Kyung Won Incheon Oriental Medicine Hospital. The
patients were blinded to group allocation. The outcome
assessment and the statistical analysis were performed by
professionals who were blinded to the assignment of
patients to either real or sham acupuncture (Figure 1).
Study duration
October 2008-June 2010
Participants
Patients aged between 18 and 65 years with non-radicular
chronic low back pain of mechanical origin were
recruited.
Inclusion criteria
Inclusion criteria were developed mainly to exclude
patients with specific or complicated low back pain.
• Between 18 and 65 years of age
• Low back pain lasting for at least the previous 3 
months
• ≥ 5 points on a 10-cm visual analog scale for bother-
someness of low back pain at the time of screening
• Intact on neurological examination (e.g., lum-
bosacral nerve function, deep tendon reflexes, plantar 
response, voluntary muscle activation, and sensory 
function)
• Non-specific, uncomplicated low back pain, i.e., 
ICD-10 (International Classification of Diseases-10) 
codes:
M51.3 Other specified intervertebral disc degenera-
tion
M54.5 Low back pain
M54.8 Other dorsalgia
M54.9 Dorsalgia, unspecified
S33.5 Sprain and strain of lumbar spine
S33.6 Sprain and strain of sacroiliac joint
S33.7 Sprain and strain of other and unspecified parts
of lumbar spine and pelvis
• Participation agreement and signed informed con-
sent
Exclusion criteria
• Radicular pain
• Pain mainly below the knee, as clinical outcome is 
likely to vary
• Serious spinal disorders, including malignancy, ver-
tebral fracture, spinal infection, inflammatory spon-
dylitis, and cauda equina compression
• Patients who previously had spinal surgery or are 
scheduled to have one during the study
• Other chronic diseases that could interfere with 
acupuncture treatment effects, including cardiovas-
cular disease, diabetic neuropathy, fibromyalgia, 
rheumatoid arthritis, dementia and epilepsy
• Chief musculoskeletal pain other than back pain
• Acupuncture treatment for low back pain during the 
previous month
• Conditions where acupuncture might not be safe, 
including clotting disorders, administration of an 
anticoagulant agent, pregnancy, and seizure disorders
• Severe psychiatric or psychological disorder
• Inability to read and write Korean
• Pending lawsuits/receiving compensation due to low 
back pain
• Patient taking corticosteroids, narcotics, muscle 
relaxant or herbal medicine to treat low back pain or 
any medication considered to be inappropriate by the 
investigator
• Refusal to participate in the trial or informed con-
sent
Figure 1 Study sequence; Process of recruitment, randomization 
to treatment, and outcome assessment.
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Recruitment
Participants were recruited through advertisements in
local newspapers, the hospital monthly magazine, on a
website and on bulletin boards. If patients were interested
in participating, they were asked to answer questions to
determine eligibility. If eligible, they were guided through
the informed consent process. After written consent was
obtained, a study researcher administered the baseline
questionnaire followed by random allocation to either the
real or sham acupuncture group. After randomization,
the interviewer scheduled the treatment procedure.
Randomization procedures
The patients were randomized per center in order to give
each investigator the same chance to use individual, stan-
dard, and sham acupuncture to control the selection bias
of the trial. The random code for randomization was gen-
erated by the medical statistician and was kept by a clini-
cian who did not contact patients.
Randomization was performed only after a subject was
confirmed to be eligible and written informed consent
was obtained. Subject details were recorded and a treat-
ment arm and randomization number were allocated to
the subject, and both of these were recorded in the sub-
ject's hospital file. The randomization form will be com-
pleted and returned to the principal investigator.
In order to ensure balance within the two groups,
blocked randomization was employed. This was made
possible by using computer-generated random numbers
from SAS software or other computer software. Different
block sizes can be used. For a block of four, the possible
assignment orders are AABB, ABAB, ABBA, etc. If there
is an important predictor of outcome, stratified block
randomization is available. For example, gender may be a
strong predictor, and then block randomization within
each of the two strata, male and female can be performed.
The blinding credibility of the real and sham acupuncture
treatments were evaluated at the baseline and at the end
of the 6-week treatment.
Education of acupuncturists
Licensed Korean Medicine Doctors (KMDs) who special-
ize in Korean Rehabilitation Medicine from the three par-
ticipating hospitals should take the educational course to
strictly adhere to the study protocol and to be familiar
with administering study treatments; all participating
KMDs underwent intensive and customized training for a
full understanding of the "sham acupuncture" procedure,
including details such as acupuncture points, depth, and
manipulation. They were also trained to administer real
acupuncture using a sham needle device.
Treatment details
Both real and sham acupuncture groups received a total
of 10-12 acupuncture sessions (approximately two times
a week, for 6 weeks). In the real acupuncture group, dis-
posable sterile needles (40 mm × 0.25 mm) were used
(Dong-bang Acupuncture Inc., Seoul, Korea), while non-
penetrating sham needles with identical gauge were used
in the sham control group (Acuprime Co., Ltd, UK). At
the time of the first acupuncture session, all participants
received an "exercise manual for low back pain patients"
from the spine center of East-West Neo Medical Center
of Kyung Hee University and were encouraged to do exer-
cises according to the manual during the whole treatment
period. This manual includes information on physical
activity, exercise and appropriate life-style modification.
• Real acupuncture A pre-defined, individualized acu-
puncture prescription in accordance with the characteris-
tics of pain was employed. For this study, we developed a
flexible treatment protocol by selecting a group of points
that were predefined in every case, allowing the partici-
pating KMD some flexibility in the choice according to
the diagnosis. The predefined points were carefully
selected by a process of consensus with participating
KMDs who were all experienced in low back pain. When
we treated the patients in this research, we chose acu-
puncture points after the process of the meridian pattern
identification. To treat low back pain, we assumed 3 types
of meridian pattern identification according to the pain
location (A: Gallbladder meridian pattern, B: Bladder
meridian pattern, C: Mixed pattern).
The acupuncture points included: Shenshu (BL23),
Qihaishu (BL24), Dachangshu (BL25), Yimmen (BL37),
Weizhong (BL40), Wangu (GB12), Daimai (GB26), Huan-
tiao (GB30), Yanglingquan (GB34), Zulinqi (GB41),
Dicang (ST4), Zusanli (ST36), Fushe (SP13), Fujie (SP14),
Yaoyangguan (GV3), Mingmen (GV4), Xuanshu (GV5),
Shenting (GV24) and Shuigou (GV26).
Acupuncture treatment was given using a sterile, dis-
posable stainless steel needle (40 mm × 0.25 mm) with
the aid of the tube of a sham acupuncture needle device.
After the skin sterilization, the needles were inserted per-
pendicular to a depth of 5-20 mm with the patient lying
down and blindfolded, followed by bidirectional rotation
to induce Deqi sensation. The needles were left in place
for 15-20 minutes.
As the real acupuncture group received treatment that
reflects everyday practice, the acupuncture points were
varied from visit to visit when the symptoms or pain
changed.
• Sham acupuncture Non-penetrating sham needles by
Park et al. (Acuprime Co., Ltd, UK)[12] were used. Eight
pre-defined points in the lower back, which are non-tra-
ditional acupuncture points, were used after skin steril-
ization, with patients lying down; 1 cm below from
Weiyang (BL39), 1 cm lateral to Ganshu (BL18), 1 cm lat-
eral to Pishu (BL20), and 2 cm above from Huantiao
(GB30), all bilaterally. The technique did not vary in anyLee et al. BMC Musculoskeletal Disorders 2010, 11:118
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way from that performed in the real acupuncture group,
except for the usage of a semi-blunted needle. The sham
needles were left in for 15-20 minutes of the session, as
was done in the real acupuncture group.
Outcome measurements
Patient completed a series of measurements to assess
back pain-related dysfunction, pain, quality of life, and
back pain-related costs.
At the screening visit, patients were asked to fill out a
questionnaire regarding age, gender, marital status, resi-
dence, occupation, and education. Medical history was
also taken before physical check-ups and it was deter-
mined whether the patient would be included or not. The
baseline (T0), 4 (T1), 6 (T2), 8 (T3), 12 (T4), and 24 (T5)
week follow-up measurements are summarized in Table
1.
Primary outcome measures
The primary outcome was measured using the visual ana-
logue scale (VAS) for bothersomeness of low back pain.
Since our intension was not to simply evaluate the sever-
ity of pain, but also to understand the impact of chronic
low back pain on the patients' life, we used the VAS not
for pain intensity, but for bothersomeness of low back
pain, as a primary outcome measurement. The patient
was asked to mark, on a 10-cm VAS (0, absence of both-
ersomeness; 10, the worst bothersomeness imaginable),
the degree of bothersomeness due to low back pain expe-
rienced within the most recent one week from the day the
assessment was performed. This measurement has sub-
stantial validity; it is highly correlated with measures of
function and other outcome measures[13]. Bothersome-
ness of low back pain was measured at baseline, and on
the 4, 6, 8, 12, and 24-week follow-ups. The primary end-
point was the 8 week follow-up, i.e. 2 weeks after comple-
tion of the 10-12 sessions of acupuncture treatment.
Secondary outcome measures
There is ample evidence supporting the validity of the
visual analogue scale (VAS) for pain intensity. Many stud-
ies have demonstrated the validity of its construct and its
reliability [14,15]. This is a fast and straightforward
method for evaluating the subjective intensity of pain.
Pain intensity was measured in the same fashion as VAS
for bothersomeness (0, absence of pain; 10, the worst pain
imaginable) at baseline, 4, 6, 8, 12 and 24 weeks after
beginning of treatment.
The Oswestry Disability Index (ODI) [16] was used to
measure back pain-related dysfunction. ODI includes 10
questions about daily activities including pain intensity,
personal care, lifting, walking, sitting, standing, sleeping,
sexual life, social life, and traveling. Each question is rated
on a 0 to 5 point scale and the lower the score, the less
disabled. It takes 5 minutes to complete and the validated
Korean version of ODI [17] was administered at baseline,
6, 8, 12, and 24-week follow-ups.
Health-related quality of life was measured at baseline,
and at 6, 8, 12, and 24-week follow-ups, using the well-
validated SF-36 [18], which has been recommended for
Table 1: Schedule for data collection; outcome measures per visits
Measures Baseline (0-week) 4-week End of treatment (6-week) 8-week 12-week 24-week
Sociodemographic characteristics X
Back pain history X
X-ray X X
VAS for bothersomeness of low back 
pain
XX X X X X
VAS for pain intensity X X X X X X
Oswestry disability Index (ODI) X X X X X
General health status (SF-36) X X X X X
EuroQol-5D (EQ-5D) X X X X X
Beck Depression Inventory (BDI) X X X X X
Medication use X X X
Costs of back care X X X X
Adverse experiences* X X X
Credibility test† X X
Acupuncture experience (In-depth 
interview)§
X
*, At every single visit; †, After 1st treatment and at the end of treatment (6-week); §, 10 randomly chosen participants (5 from acupuncture group 
and 5 from sham group) for each hospital, thus 30 in total.Lee et al. BMC Musculoskeletal Disorders 2010, 11:118
http://www.biomedcentral.com/1471-2474/11/118
Page 5 of 7
back pain studies. The SF-36 measures 8 health domains:
1) limitations in physical activity because of health prob-
lem; 2) limitations in social activities because of physical
or emotional problem; 3) limitations in usual role activi-
ties because of physical health problems; 4) bodily pain;
5) general mental health (psychological distress and well-
being); 6) limitations in usual activities because of emo-
tional problems; 7) vitality (energy and fatigue); and 8)
general health perceptions. The higher score means bet-
ter general health status. In our study, the validated
Korean version of SF-36 [19] was analyzed.
Patients completed the EuroQol 5-Dimension (EQ-5D)
[20] at baseline, and at the 6, 8, 12 and 24-week follow-
ups. EQ-5D is a generic questionnaire that measures the
quality of life regarding personal health. It consists of two
parts: in the first part, the patient evaluates in a descrip-
tive way his/her health state, with respect to 5 dimen-
sions, namely mobility, personal care, daily activities,
pain/discomfort and anxiety/depression. Each dimension
is scored from one to three, and so the best possible
health profile is 11111 and the worst is 33333. In the sec-
ond part, the patient rates on a VAS from 0, the worst
imaginable state of health to 100, the best imaginable
state of health, his/her overall state of health on the day
the questionnaire is completed. The two scores are com-
plementary. EQ-5D has an index of reference value of
possible health profiles ranging from a value of one (the
best state of health) to zero (death). Thus, we sought to
combine these results with the years of life in order to cal-
culate the years of life adjusted for health-related quality
of life. Using this approach, as well as analyzing cost-
effectiveness, we performed a cost-utility analysis. A vali-
dated Korean version of EQ-5D [21] was administered in
this study.
The Korean version of Beck's Depression Inventory
(BDI) [22] is a 21-item self-administered questionnaire. It
provides a quantitative measure of depressive symptoms.
Each item has a 0-3 response format, giving a theoretical
maximum score of 63. The following cut-off scores are
recommended: scores 0-9 little, if any, depression, 10-18
mild depression, 19-29 moderate depression, and 30-63
severe depression. The psychometric quality of the ques-
tionnaire is very good [23]. The validated Korean version
of the credibility test, which was first proposed by Vin-
cent [24], was used to assess the credibility of real and
sham acupuncture treatments at the end of the 6-week
treatment. The patients rated the credibility of the treat-
ment they were given by answering 4 questions on a
numeric rating scale, with 0 for not at all and 6 for maxi-
mal agreement: 1) improvement expected; 2) recommen-
dation to others; 3) treatment logical; and 4) effective also
for other diseases.
Protection of subjects and assessment of safety
Any adverse experiences at any clinic visit during the 12
sessions were monitored. The research team monitored
serious adverse experiences, which were defined as treat-
ment-related experiences.
Stopping rules
The trial would have been stopped if the principle investi-
gator believed there was an unacceptable risk of serious
adverse events in one of more of the treatment arms.
Sample size determination
Generally, a level of significance of α = 0.05 and a power
of 1-ß = 0.80 were used. For two arms (control - sham
acupuncture, experimental - real acupuncture), we con-
sidered the two sample t-test model.
Experimental group: real acupuncture
Control group: sham acupuncture
Primary parameter: VAS for bothersomeness at 2
months after beginning of treatment
Expected mean difference and common standard 
deviation between two groups: 1.5 on a 0-10 VAS for 
bothersomeness, SD = 2.73
Drop-out rate: 20%
Sample size determination:
where,
N : total sample size
nt : sample size for experimental group
nc : sample size for control group
r: number of experimental group
s: number of control group
λ: ratio of experimental and control sample size (λ = 
nt/nc)
In the trial, r = 1, s = 1 and λ = 1 were assumed, and
then N = nt + nc 
To determine optimal sample size, we considered the
following hypotheses of interest and formulas of sample
size
Under hypotheses H0: μc = μt H1: μc ≠ μt 
sample size:
μt : mean of experimental group
μc : mean of control group
σ2 : common variance between two groups
α: probability of type 1 error (significance level)
Nr n s n tc =+ (1)
nn
ZZ
c- t
tc ==
+ () + ()
()
al 22 2 1
2
βσλ
μμ
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ß: probability of type 2 error
Zα/2: α/2th quantile of standard normal distribution
Zß : ßth quantile of standard normal distribution
μc-μt = 1.5, σ = 2.73(Reference: Cherkin et al)[25]
Using formulas (1) above:
For the equal allocation for the two groups, total sam-
ple size considering drop-out rate of 20% was calculated
as 130 subjects.
Statistical methods and analysis
All statistical analysis was performed in the principle of
ITT analysis (Intention-To-Treat analysis) and PP analysis
(Per-Protocol analysis). In the case of ITT analysis, we
applied the LOCF (Last Observation Carried Forward
Analysis) rule. For all statistical analysis, SPSS Win.
Ver.14.0 and a significance level of 0.05 were used.
Description of baseline characteristic and homogeneity test 
of two groups
For the description of baseline characteristics, both
demographical and clinical, for all subjects in the clinical
trial, the mean with standard deviation, range with mini-
mum and maximum for quantitative data and frequency
with percentage for qualitative data are described.
For the homogeneity test of the baseline characteristics,
both demographical and clinical, between the two
groups, two-sample t-test for quantitative data and Chi-
square test for qualitative data were performed. If there
were baseline characteristics showing statistical signifi-
cance and possibility of covariance, ANCOVA (analysis of
covariance) was used for analysis and adjustment of base-
line characteristics.
Efficacy
• Primary variable The two-sample T-test was used for
VAS for bothersomeness of low back pain at baseline and
at 8 weeks for the comparison of the two groups and to
determine differences from baseline. ANCOVA and two-
sample T-test was used between the differences at base-
line VAS and 8 week VAS for each groups. Also, a 95%
confidence interval was added for all analyses.
Repeated measure two factor analysis will be used to
analyze the difference and mean change among baseline,
and 4, 6, 8, 12 and 24-week VAS, difference and mean
change between groups, and interaction between groups
and observed time. If necessary, a mixed model approach
was also used.
• Secondary variable and others For the variable, VAS
for pain intensity, Oswestry Disability Index (ODI), SF-
36, EQ-5D, repeated measure two factor analysis was
used to analyze the difference and mean change among
baseline, 4, 6, 8, 12 and 24-week VAS, difference and
mean change between groups, and interaction between
groups and observed time. If necessary, a mixed model
approach was also used.
For medication use, the Chi-square test was used to
analyze the different types of drugs between the groups,
dose of drug and frequency of dose in a day among base-
line, 4, 6, 8, 12 and 24-week VAS. Repeated measure two
factor analysis was used to analyze the difference and
mean change between groups, interaction between
groups and observed time. If necessary, a mixed model
approach was also used.
Safety
All adverse effects were recorded and described as fre-
quency and percentage. For the comparison of adverse
effects between groups, the Chi-square test or Fisher's
exact test were performed.
Data handling
Investigators entered the information required by the
protocol into the Case Report Forms (CRFs). Non-obvi-
ous errors or omissions were entered into data query
forms, which were returned to the investigational site for
resolution. The data from all centers were gathered and
summarized with respect to demographic baseline char-
acteristics, effectiveness and safety observations.
Discussion
We adopted the visual analogue scale for bothersomeness
(not pain) as the primary outcome measurement. This is
because the target disease of this study is chronic low
back pain. According to the clinical experience, we
observed that some patients with chronic pain tend to be
very bothered by even a small amount of pain and others
are not bothered by even moderate pain. In clinical prac-
tice, we frequently find it is more essential and effective
to try to improve bothersomeness due to chronic pain
than to try to reduce that pain itself.
V a r i o u s  r a n d o m i z e d  c l i n i c a l  t r i a l s  t h a t  h a v e  i n v e s t i -
gated the efficacy of acupuncture tend to use different
types of control groups, such as sham acupuncture, pla-
cebo acupuncture and a waiting list [8,9,26,27]. In this
study, we chose placebo acupuncture (non acupuncture
points) combined with sham acupuncture device. We
a a =− = → == = = 00 51 08 0 19 6 0 08 4 2 ., . . , . β β ZZ Z Z 0.025 0.20
(3)
nt nc
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c- t
==
+ () + ()
()
=
+ () ( ) ⋅
a 22 2 1
2
1 960 0 842 2 27 3 2 2
15
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μμ
.. .
. 2 2
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believe that it is more valid to combine placebo acupunc-
ture with sham acupuncture as the control group, in
order to isolate the specific effects of the technique from
the non-specific analgesic ones.
The results of this trial will be available in July 2010
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